Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.56 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | CA7 | P43166 | 3/20 | 0.56 |
| ▸ | CA9 | Q16790 | 3/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4318585 | 0.89 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1664013 | 0.84 | CA12 (0.75) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2810136 | 0.79 | NPC1 (0.68) | CA12CA1CA2CA7CA9 | |
| SCHEMBL666091 | 0.79 | CA12 (0.52) | CA12CA1CA2CA7CA9 | |
| SCHEMBL265366 | 0.78 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| Potassium SCHEMBL29912694 | 0.77 | CA12 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29912668 | 0.77 | CA12 (0.50) | CA12CA1CA2CA7CA9 | |
| SCHEMBL2712707 | 0.76 | CA12 (0.64) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7234951 | 0.76 | CYP2C19 (0.70) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16175866 | 0.76 | KDM4E (0.68) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9340660-B2 | Poly(3-hydroxyalkanoate) resin composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-05-17 | — | — | US | disclosed |
| EP-2479181-B1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT AND THERMOPLASTIC RESIN COMPOSITION CONTAINING PHOSPHONIC ACID METAL SALT | NISSAN CHEMICAL IND LTD (JP) | 2016-04-20 | — | — | EP | disclosed |
| EP-2431374-B1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT FINE PARTICLES | NISSAN CHEMICAL IND LTD (JP) | 2016-03-30 | — | — | EP | disclosed |
| US-9035100-B2 | Method for producing phenylphosphonic acid metal salt composition, and crystal nucleating agent therefrom | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-05-19 | — | — | US | disclosed |
| US-20140330038-A1 | METHOD FOR PRODUCING PHENYLPHOSPHONIC ACID METAL SALT COMPOSITION, AND CRYSTAL NUCLEATING AGENT THEREFROM | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-11-06 | — | — | US | disclosed |
| US-20140235771-A1 | POLY(3-HYDROXYALKANOATE) RESIN COMPOSITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-08-21 | — | — | US | disclosed |
| US-8445718-B2 | Method for producing phosphonic acid metal salt fine particles | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-05-21 | — | — | US | disclosed |
| EP-2479181-A1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT AND THERMOPLASTIC RESIN COMPOSITION CONTAINING PHOSPHONIC ACID METAL SALT | Nissan Chemical Industries, Ltd. (JP) | 2012-07-25 | — | — | EP | disclosed |
| EP-2431374-A1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT FINE PARTICLES | Nissan Chemical Industries, Ltd. (JP) | 2012-03-21 | — | — | EP | disclosed |
| US-20120046397-A1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT FINE PARTICLES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-02-23 | — | — | US | disclosed |
| EP-1736510-B1 | POLYLACTIC ACID RESIN COMPOSITION | NISSAN CHEMICAL IND LTD (JP) | 2011-12-21 | — | — | EP | disclosed |
| US-20110196077-A1 | PRODUCTION PROCESS OF PHOSPHONIC ACID METAL SALT AND THERMOPLASTIC RESIN COMPOSITION CONTAINING PHOSPHONIC ACID METAL SALT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2011-08-11 | — | — | US | disclosed |
| US-7531585-B2 | Polyactic acid resin composition | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-05-12 | — | — | US | disclosed |
| US-20070299170-A1 | Containing zinc phenyl phosphonate as crystal nucleator appropriate for accelerating crystallization; heat resistance and forming processability | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-12-27 | — | — | US | disclosed |
| EP-1736510-A1 | POLYLACTIC ACID RESIN COMPOSITION | Nissan Chemical Industries, Ltd. (JP) | 2006-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110196077-A1 | PRODUCTION PROCESS OF PHOSPHONIC ACID METAL SALT AND THERMOPLASTIC RESIN COMPOSITION CONTAINING PHOSPHONIC ACID METAL SALT | PPA1, PHOSPHO1, PRPS1 | CA12 1812/4885CA1 475/4885CA2 577/4885 |
| US-20120046397-A1 | METHOD FOR PRODUCING PHOSPHONIC ACID METAL SALT FINE PARTICLES | PHOSPHO1, PLA2G2C, ACP1 | CA12 47/4885CA1 13/4885CA2 9/4885 |
| US-20140330038-A1 | METHOD FOR PRODUCING PHENYLPHOSPHONIC ACID METAL SALT COMPOSITION, AND CRYSTAL NUCLEATING AGENT THEREFROM | NPM1, MPHOSPH6, PPA1 | CA12 999/4885CA1 562/4885CA2 214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.